N-[4-(3-amino-1,9-dioxo-1,4,5,6,6a,7,9,10-octahydro-8H-pyrazino[1,2-f]pteridin-8-yl)benzoyl]glutamic acid (80402-38-6)

Identification
Name:	N-[4-(3-amino-1,9-dioxo-1,4,5,6,6a,7,9,10-octahydro-8H-pyrazino[1,2-f]pteridin-8-yl)benzoyl]glutamic acid
CAS:	80402-38-6
Molecular Formula:	C₂₁H₂₃N₇O₇
Molecular Weight:	485.45
InChI:	InChI=1/C21H23N7O7/c22-21-25-17-16(19(33)26-21)28-9-14(29)27(8-12(28)7-23-17)11-3-1-10(2-4-11)18(32)24-13(20(34)35)5-6-15(30)31/h1-4,12-13H,5-9H2,(H,24,32)(H,30,31)(H,34,35)(H4,22,23,25,26,33)
Molecular Structure:
Properties
Density:	1.76g/cm³
Refractive index:	1.798
Safety Data

Other Product

N-[4-(3-amino-1-oxo-1,4,5,6,6a,7,9,10-octahydro-8H-pyrazino[1,2-f]pteridin-8-yl)benzoyl]glutamic acid
N-{4-[(9E)-3-amino-9-imino-1-oxo-1,4,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl}glutamic acid
L-Glutamic acid,N-[4-[(6aR)-3-amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl]-
L-Glutamic acid,N-[4-(3-amino-1,2,5,6,6a,7-hexahydro-1-oxoimidazo[1,5-f]pteridin-8(9H)-yl)benzoyl]-
N-{4-[(6aR)-3-amino-1-oxo-1,4,5,6,6a,7-hexahydroimidazo[1,5-f]pteridin-8(9H)-yl]benzoyl}glutamic acid
L-Glutamic acid, N-(4-(3-amino-1,5,6,6a,7,8-hexahydro-1-oxo-2H-pyrimido(1,6-f)pteridin-9(10H)-yl)benzoyl)-, monoformate
L-Glutamic acid,N-[4-(3-amino-1,5,6,6a,7,8-hexahydro-1-oxo-2H-pyrimido[1,6-f]pteridin-9(10H)-yl)benzoyl]-, (R)-
1/C10H17NO/c12-10-7-4-8-11(10)9-5-2-1-3-6-9/h9H,1-8H
Spiro[furo[3,2-b]furan-2(5H),10'-[8H-3,8a]methanodifuro[2,3-b:3',4'-f]oxepin]-2',5,8'(3'H)-trione,6'-(3-furanyl)-3,3a,3'a,5'a,6,6',6a,9'a-octahydro-3',5'a,9'a-trimethyl-3a-(1-methylethenyl)-,(2S,3'S,3aR,3'aS,5'aS,6aS,6'S,8'aR,9'aR)- (9CI)
1/C9H15NO/c1-2-4-9(3-1)10-5-7-11-8-6-10/h3H,1-2,4-8H
L-Glutamic acid,N-[4-(3-amino-1,2,5,6,6a,7,9,9a-octahydro-1-oxo-8H-pyrrolo[3',4':4,5]pyrido[2,3-d]pyrimidin-8-yl)benzoyl]-
1/C11H10O2/c1-9(12)3-4-10-5-7-11(13-2)8-6-10/h5-8H,1-2H
N-{4-[{[2-amino-4-(methylsulfanyl)pteridin-6-yl]methyl}(methyl)amino]benzoyl}glutamic acid
N-[4-[[(2-AMino-6,7,8,9-tetrahydro-8-Methyl-4,9-dioxo-4H-pyrazino[1,2-a]-1,3,5-triazin-7-yl)Methyl]aMino]benzoyl]-L-glutaMic Acid
1/C6H8N2O/c7-4-2-1-3-5(9)6(4)8/h1-3,9H,7-8H
1H-Imidazo[1,5-f]pteridin-10-ium, 3-amino-8-[4-[[[(1S)-1,3-dicarboxypropyl]amino]carbonyl]phenyl]-2,5,6, 6a,7,8-hexahydro-1-oxo-, chloride
1/C12H17NO2/c14-11-4-2-1-3-9(11)7-10-8-12(5-6-12)15-13-10/h9H,1-8H
L-Glutamic acid,N-[4-(3-amino-1,5,6,6a,7,8,10,10a-octahydro-1-oxopyrimido[4,5-c][2,6]naphthyridin-9(2H)-yl)benzoyl]-,(6aR-cis)- (9CI)
1/C10H14N2O/c1-3-12(4-2)10(13)9-5-7-11-8-6-9/h5-8H,3-4H2,1-2H
[10'-(formyloxy)-3',9'-dihydroxy-2,4b',8'-trimethyl-1',4'-dioxo-3',4',4b',5',6',7',8',8a',9',10'-decahydro-1'H-spiro[cyclopropane-1,2'-phenanthren]-8'-yl]acetic acid (non-preferred name)